You are here: Industry Insights > Cell Therapy

News List

Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing WorldPharmaNews
January 26, 2022
Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a Series A financing of $80 million, led by the impact investment arm of Bayer AG - Leaps by Bayer - 8VC, and Humboldt Fund.
Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma prnasia
December 23, 2021
Lion TCR Pte Ltd today announced that it has received Fast Track Designation from United States Food and Drug Administration (U.S. FDA) for LioCyx-M004, autologous T-cells transfected with mRNA encoding Hepatitis B surface antigen...
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021 WorldPharmaNews
December 21, 2021
Novartis announced the introduction of T-Charge™, the company's next-generation CAR-T platform that will serve as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline.
Quell raises $156m Series B funds to develop cell therapies Pharmaceutical-Business-Review
November 30, 2021
Quell Therapeutics has raised $156m funding through an oversubscribed Series B funding round to advance its multi-modular engineered T regulatory (Treg) cell therapy pipeline and platform.
Link Health to obtain global rights for Bone Therapeutics’ cell therapy Pharmaceutical-Technology
November 30, 2021
Link Health Pharma has entered a non-binding term sheet to acquire worldwide rights for Bone Therapeutics’ allogeneic bone cell therapy, ALLOB.
Lykan Bioscience Bolsters Cell Therapy Capabilities ContractPharma
November 11, 2021
Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based therapies, has unveiled plans to expand its state-of-the-art, purpose-built facility in Hopkinton...
PBS Biotech secures $10 million to expand cell therapy manufacturing equipment portfolio cphi-online
August 19, 2021
The capital will be used to expand and industrialise the company's range of single-use bioreactor systems and contract process development services
Astellas and Minovia Therapeutics to Collaborate on New Mitochondrial Cell Therapies americanpharmaceuticalreview
August 02, 2021
Minovia Therapeutics, Ltd. and Astellas Pharma Inc. announced a worldwide strategic collaboration and license agreement for the research, development, and commercialization of novel cell therapy programs for diseases caused by mitochondrial dysfunction.
BioNTech to Acquire Kite’s TCR Cell Therapy Platform and Mfg. Facility contractpharma
July 20, 2021
BioNTech SE and Kite, a Gilead Company, have entered a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in Gaithersburg, MD.
Senti Bio Invests in Cell Therapy Manufacturing Facility contractpharma
June 24, 2021
92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of allogeneic CAR-NK cell pipeline.

Previous page 1 2 3 4 5 6 7 8 Next page